8-K: Genasys Amends Nicoya Pact, Repays $4M Loan

Genasys Inc. has amended its cooperation agreement with Nicoya Capital, nominating new directors and repaying a $4 million term loan.

Summary

• Genasys Inc. entered into an Amended and Restated Cooperation Agreement (A&R Cooperation Agreement) with Nicoya Capital LLC and its affiliates on December 19, 2025, amending and restating a previous agreement from January 14, 2025.
• The company agreed to nominate Richard S. Danforth, Susan Lee Schmeiser, William H. Dodd, W. Craig Fugate, and R. Rimmy Malhotra (the Nicoya Appointee) for election to the Board of Directors at the 2026 Annual Meeting of Stockholders.
• Genasys will collaborate with the Investor Parties to identify a mutually acceptable nominee to serve as a director and Chair of the Audit Committee.
• If a mutually acceptable Audit Committee Chair nominee is not identified and agreed upon prior to the filing of the company's quarterly report for the period ending June 30, 2026, R. Rimmy Malhotra will serve as interim Chair of the Audit Committee.
• Richard H. Osgood III and Mark Culhane will serve on the company's strategic advisory committee beginning with the date of the 2026 Annual Meeting.
• Mark Culhane will not stand for re-election at the 2026 Annual Meeting, but this is not due to any disagreement with the company's operations, policies, or practices.
• Nicoya Capital agreed to abide by certain standstill restrictions during the term of the A&R Cooperation Agreement.
• The agreement includes procedures for replacing Mr. Malhotra and a mutual non-disparagement provision.
• On December 29, 2025, Genasys repaid in full an additional $4 million term loan, plus related interest and fees, which was extended pursuant to an amendment dated May 9, 2025.
• A $15 million term loan extended on May 13, 2024, remains outstanding.

Sentiment

Score: 6

Explanation: The filing indicates positive steps in debt reduction and board alignment with a key investor. However, the ongoing $15 million debt and the contingency for the Audit Committee Chair introduce some uncertainty, preventing a higher score.

Positives

• Repayment of the $4 million term loan reduces debt and associated interest expenses, improving the company's financial liquidity.
• The Amended and Restated Cooperation Agreement with Nicoya Capital, a significant investor, suggests a formalized alignment on board composition and strategic direction, potentially leading to greater stability.
• The nomination of five directors, including the Nicoya Appointee, aims to strengthen board oversight and bring diverse expertise.
• The establishment of a strategic advisory committee with experienced individuals like Richard H. Osgood III and Mark Culhane could provide valuable strategic guidance to the company.

Negatives

• The $15 million term loan from May 2024 remains outstanding, indicating continued significant debt obligations.
• The provision for R. Rimmy Malhotra to serve as interim Chair of the Audit Committee if a mutually acceptable nominee is not found by June 30, 2026, could signal potential challenges or delays in securing an independent Audit Committee Chair.
• Standstill restrictions on Nicoya Capital limit their ability to engage in certain activist behaviors outside the agreed terms, which might be viewed as a limitation on shareholder influence by some investors.

Risks

• Failure to identify a mutually acceptable Audit Committee Nominee by the June 30, 2026 quarterly report filing could lead to R. Rimmy Malhotra serving as interim Chair, potentially raising questions about governance stability or independence.
• The ongoing $15 million term loan represents a significant financial obligation that needs to be managed, and its terms could impact future financial flexibility.
• A material breach of the A&R Cooperation Agreement by either Nicoya or the company could lead to its termination and potential disputes, disrupting board stability and investor relations.

Future Outlook

The company is focused on strengthening its board and governance structure through the amended cooperation agreement, aiming for a mutually acceptable Audit Committee Chair. The repayment of a portion of its debt indicates a move towards financial stability, though a significant loan remains.

Management Comments

• The Board has deemed it in the best interests of the Company to enter into this Agreement and has authorized the Company to enter into this Agreement.
• Mark Culhane will not stand for re-election, which is not because of a disagreement with the Company on any matter relating to the Company's operations, policies or practices.

Industry Context

na

Management Changes

Corporate Governance

Related Party Transactions

• The Amended and Restated Cooperation Agreement was entered into with Nicoya Capital LLC, Nicoya Fund LLC, and Nicoya Genasys-SPV LLC, which are affiliates of Company director R. Rimmy Malhotra. This constitutes a related party transaction.

Stakeholder Impact

• **Shareholders:** The agreement with Nicoya Capital, a significant investor, could lead to more stable governance and strategic direction. The repayment of debt may improve financial health. Standstill provisions limit Nicoya's ability to engage in certain activist behaviors, which could be viewed differently by various shareholders.
• **Board of Directors:** Changes in board composition and roles, including new nominees and the formation of a strategic advisory committee, will impact board dynamics and oversight.
• **Creditors:** Repayment of the $4 million term loan is positive for creditors, reducing the company's immediate debt burden. The remaining $15 million loan still represents an obligation.

Next Steps

• Identify a mutually acceptable nominee for Chair of the Audit Committee.
• Hold the 2026 Annual Meeting of Stockholders for director elections.
• Richard H. Osgood III and Mark Culhane to begin serving on the strategic advisory committee after the 2026 Annual Meeting.
• R. Rimmy Malhotra to serve as interim Chair of the Audit Committee if a nominee is not identified by the June 30, 2026 quarterly report filing.

Key Dates

Recommendation

The repayment of the $4 million loan is a positive step in debt management, and the cooperation agreement with a significant investor like Nicoya Capital suggests a more aligned and stable governance structure. However, the remaining $15 million debt and the contingency around the Audit Committee Chair appointment introduce some uncertainty. The standstill agreement limits potential activist pressure from Nicoya, which could be seen as both positive (stability) and negative (less external pressure for change). Overall, the news is neutral to slightly positive, warranting a 'hold' as the company navigates these governance and financial adjustments.

Keywords

Genasys Inc., GNSS, SEC filing, 8-K, cooperation agreement, Nicoya Capital, board of directors, corporate governance, director nominations, audit committee, term loan, debt repayment, standstill agreement, shareholder agreement